Instant-View hCG Combo II Cassette Test
Alfa Scientific Designs, Inc. · Decision date Sep 22, 2026
What did the FDA decide?
Alfa Scientific Designs, Inc. received FDA clearance for the Instant-View® hCG Combo II Cassette Test under 510(k) K262299, decided September 22, 2026, with a substantially equivalent (SESE) determination. The submission was received July 7, 2026, reviewed under regulation 862.1155 in the Clinical Chemistry panel, product code JHI, as a traditional 510(k) not reviewed by a third party. SESE is a clearance to market, not a PMA approval.
The device is described in the review documents as a chromatographic immunoassay for qualitative detection of human chorionic gonadotropin in urine or serum, intended as an aid in early pregnancy detection and for health care professional use only, not self-testing. CLIA records effective September 23, 2026 list urine hCG by visual color comparison as waived and qualitative serum hCG as moderate complexity. The source does not state performance data, prior predicate identity, or any change from earlier versions.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Sep 22, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262299
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Alfa Scientific Designs, Inc.
- Product code
- JHI
- Decision code
- SESE
- Decision date
- Sep 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Visual, Pregnancy Hcg, Prescription Use.
- Applicant
- Alfa Scientific Designs, Inc.
- Product code
- JHI
- FDA device class
- 2
FDA decision timeline
K262299 received
Application receipt date recorded by FDA.
K262299 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Alfa Scientific Designs, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Powat, CA
Sources and methodology
- Original FDA record: K262299
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records